HPV16 Sublineage Associations with Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women

Journal of the National Cancer Institute

Volumn 108, Issue 9, 2016, Pages

  Mirabello, Lisa ^a   Yeager, Meredith ^b   Cullen, Michael ^b   Boland, Joseph F ^b   Chen, Zigui ^c   Wentzensen, Nicolas ^a   Zhang, Xijun ^b   Yu, Kai ^a   Yang, Qi ^b   Mitchell, Jason ^b   Roberson, David ^b   Bass, Sara ^b   Xiao, Yanzi ^a   Burdett, Laurie ^b   Raine Bennett, Tina ^d   Lorey, Thomas ^e   Castle, Philip E ^a   Burk, Robert D ^f   Schiffman, Mark ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d DIVISION OF RESEARCH   (United States)

^e KAISER PERMANENTE   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ADENOCARCINOMA IN SITU; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; ETHNICITY; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC VARIATION; HIGH THROUGHPUT SEQUENCING; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; OUTCOME ASSESSMENT; PHYLOGENETIC TREE; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS CLASSIFICATION; VIRUS GENOME; AFTERCARE; CALIFORNIA; CARCINOMA; CLASSIFICATION; EPIDEMIOLOGY; ETHNOLOGY; GENETICS; GENOME; MIDDLE AGED; PAPILLOMAVIRUS INFECTION; PATHOGENICITY; PHYLOGENY; PRECANCER; RISK FACTOR; UTERINE CERVIX TUMOR; VIROLOGY; YOUNG ADULT;

ADENOCARCINOMA; ADENOCARCINOMA IN SITU; ADULT; AFTERCARE; CALIFORNIA; CARCINOMA; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOME; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PHYLOGENY; PRECANCEROUS CONDITIONS; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84989184550     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djw100     Document Type: Article

References (47)

1. Schiffman M, Herrero R, DeSalle R, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 2005;337:76-84.
2. Bouvard V, Baan R, Straif K, et al. A review of human carcinogens-Part B: biological agents. Lancet Oncol. 2009;10:321-322.
3. Forman D, de Martel C, Lacey CJ, et al. Global Burden of Human Papillomavirus and Related Diseases. Vaccine. 2012;30 (Suppl 5):F12-F23.
4. Bernard H-U, Burk RD, Chen Z, et al. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology. 2010;401:70-79.
5. McCredie M, Sharples K, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: A retrospective cohort study. Lancet Oncol. 2008;9:425-434.
6. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370:890-907.
7. Burk RD, Chen Z, Van Doorslaer K. Human Papillomaviruses: Genetic Basis of Carcinogenicity. Public Health Genomics. 2009;12:281-290.
8. de Sanjose S, Quint WGV, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11:1048-1056.
9. Guan P, Howell-Jones R, Li N, et al. Human papillomavirus types in 115, 789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int J Cancer. 2012;131:2349-2359.
10. Cullen M, Boland JF, Schiffman M, et al. Deep sequencing of HPV16 genomes: A new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Res. 2015;1:3-11.
11. Burk RD, Harari A, Chen Z. Human papillomavirus genome variants. Virology. 2013;445:232-243.
12. Hildesheim A, Schiffman M, Bromley C, et al. Human Papillomavirus Type 16 Variants and Risk of Cervical Cancer. J Natl Cancer Inst. 2001;93:315-318.
13. Pientong C, Wongwarissara P, Ekalaksananan T, et al. Association of human papillomavirus type 16 long control region mutation and cervical cancer. Virol J. 2013;10:30.
14. Xi LF, Koutsky LA, Hildesheim A, et al. Risk for High-Grade Cervical Intraepithelial Neoplasia Associated with Variants of Human Papillomavirus Types 16 and 18. Cancer Epidemiol Biomarkers Prev. 2007;16:4-10.
15. Schiffman M, Rodriguez AC, Chen Z, et al. A Population-Based Prospective Study of Carcinogenic Human Papillomavirus Variant Lineages, Viral Persistence, and Cervical Neoplasia. Cancer Res. 2010;70:3159-3169.
16. Cornet I, Gheit T, Iannacone MR, et al. HPV16 genetic variation and the development of cervical cancer worldwide. Br J Cancer. 2013;108:240-244.
17. Gheit T, Cornet I, Clifford GM, et al. Risks for Persistence and Progression by Human Papillomavirus Type 16 Variant Lineages Among a Population-Based Sample of DanishWomen. Cancer Epidemiol Biomarkers Prev. 2011;20:1315-1321.
18. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet. 1998;352:1441-1442.
19. Zuna RE, Moore WE, Shanesmith RP, et al. Association of HPV16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int J Cancer. 2009;125:2609-2613.
20. Sichero L, Ferreira S, Trottier H, et al. High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. Int J Cancer. 2007;120:1763-1768.
21. Berumen J, Ordonez RM, Lazcano E, et al. Asian-American Variants of Human Papillomavirus 16 and Risk for Cervical Cancer: A Case-Control Study. J Natl Cancer Inst. 2001;93:1325-1330.
22. Freitas LB, Chen Z, Muqui EF, et al. Human Papillomavirus 16 Non-European Variants Are Preferentially Associated with High-Grade Cervical Lesions. PLoS ONE. 2014;9:e100746.
23. Burk RD, Terai M, Gravitt PE, et al. Distribution of Human Papillomavirus Types 16 and 18 Variants in Squamous Cell Carcinomas and Adenocarcinomas of the Cervix. Cancer Res. 2003;63:7215-7220.
24. Quint KD, de Koning MNC, van Doorn L-J, Quint WGV, Pirog EC. HPV genotyping and HPV16 variant analysis in glandular and squamous neoplastic lesions of the uterine cervix. Gynecol Oncol. 2010;117:297-301.
25. Rabelo-Santos SH, Villa LL, Derchain SF, et al. Variants of human papillomavirus types 16 and 18: Histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in cervical smear. Int J Gynecol Pathol. 2006;25:393-397.
26. De Boer MA, Peters LAW, Aziz MF, et al. Human papillomavirus type 18 variants: Histopathology and E6/E7 polymorphisms in three countries. Int J Cancer. 2005;114:422-425.
27. Lizano M, De la Cruz-Hernandez E, Carrillo-Garca A, et al. Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol. 2006;102:230-235.
28. Xi LF, Kiviat NB, Hildesheim A, et al. Human Papillomavirus Type 16 and 18 Variants: Race-Related Distribution and Persistence. J Natl Cancer Inst. 2006;98:1045-1052.
29. Lopera EA, Baena A, Florez V, et al. Unexpected inverse correlation between Native American ancestry and Asian American variants of HPV16 in admixed Colombian cervical cancer cases. Infect Genet Evol. 2014;28:339-348.
30. Junes-Gill K, Sichero L, Maciag PC, et al. Human papillomavirus type 16 variants in cervical cancer from an admixtured population in Brazil. J Med Virol. 2008;80:1639-1645.
31. Castle P, Shaber R, LaMere B, et al. Human papillomavirus (HPV) genotypes in women with cervical precancer and cancer at Kaiser Permanente Northern California. Cancer Epidemiol Biomarkers Prev. 2011;20:946-953.
32. Bernard H-U. Coevolution of papiliomaviruses with human populations. Trends Microbiol. 1994;2:140-143.
33. Bernard H-U, Calleja-Macias IE, Dunn ST. Genome variation of human papillomavirus types: Phylogenetic and medical implications. Int J Cancer. 2006;118:1071-1076.
34. Yamada T, ManosMM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers: A worldwide perspective. J Virol. 1997; 71:2463-2472.
35. Burk RD, Ho GYF, Beardsley L, et al. Sexual Behavior and Partner Characteristics Are the Predominant Risk Factors for Genital Human Papillomavirus Infection in Young Women. J Infect Dis. 1996;174:679-689.
36. Castle PE, Schiffman M, Gravitt PE, et al. Comparisons of HPV DNA detection by MY09/11 PCR methods. J Med Virol. 2002;68:417-23.
37. Van Doorslaer K, Tan Q, Xirasagar S, et al. The Papillomavirus Episteme: A central resource for papillomavirus sequence data and analysis. Nucleic Acids Res. 2013;41:D571-D578.
38. Stamatakis A. RAxML-VI-HPC: maximum likelihood-based phylogenetic analyses with thousands of taxa and mixed models. Bioinformatics. 2006;22:2688-2690.
39. Chopjitt P, Ekalaksananan T, Pientong C, et al. Prevalence of human papillomavirus type 16 and its variants in abnormal squamous cervical cells in Northeast Thailand. Int J Infect Dis. 2009;13:212-219.
40. Day PM, Lowy DR, Schiller JT. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology. 2003;307:1-11.
41. Smith JL, Campos SK, Ozbun MA. Human Papillomavirus Type 31 Uses a Caveolin 1-and Dynamin 2-Mediated Entry Pathway for Infection of Human Keratinocytes. J Virol. 2007;81:9922-9931.
42. Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol. 2000;81:1975-1981.
43. McBride AA. Chapter 4 Replication and Partitioning of Papillomavirus Genomes. In: Advances in Virus Research. Academic Press. 2008; 155-205.
44. Mori S, Kusumoto-Matsuo R, Ishii Y, Takeuchi T, Kukimoto I. Replication interference between human papillomavirus types 16 and 18 mediated by heterologous E1 helicases. Virol J. 2014;11:11-11.
45. Fu L, Terai M, Matsukura T, Herrero R, Burk RD. Codetection of a Mixed Population of candHPV62 Containing Wild-Type and Disrupted E1 Open-Reading Frame in a 45-Year-Old Woman with Normal Cytology. J Infect Dis. 2004;190:1303-1309.
46. Chen Z, Terai M, Fu L, et al. Diversifying Selection in Human Papillomavirus Type 16 Lineages Based on Complete Genome Analyses. J Virol. 2005;79:7014-7023.
47. Smith B, Chen Z, Reimers L, et al. Sequence Imputation of HPV16 Genomes for Genetic Association Studies. PLoS ONE. 2011;6:e21375.